Pakistan’s Regulator Offers Pharmacovigilance Training Amid Compliance Challenges

Not enough companies are complying with Pakistan’s pharmacovigilance rules, according to the drug regulator, which wants to remedy the situation after a previous attempt to do so failed.

Pills capsules with Pakistani flag. 3D rendering isolated on white background
The DRAP wants to ensure all stakeholders play their role in establishing an effective pharmacovigilance system • Source: Shutterstock

The Drug Regulatory Authority of Pakistan (DRAP) is planning to conduct a series of training sessions next month to help tackle its concerns over poor compliance with pharmacovigilance requirements by most drug companies.

The training sessions will be held virtually and are aimed at registration holders (ie, manufacturers or importers of therapeutic goods),...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Safety

More from Pink Sheet